What is Thermo Fisher Scientific's deferred revenue, net of current portion?

Thermo Fisher Scientific (TMO) reported deferred revenue, net of current portion of $1.03B in Q1 2026.

What does deferred revenue, net of current portion mean?

Revenue received in advance for services or products to be delivered more than one year in the future.

Deferred revenue, net of current portion

Thermo Fisher Scientific Deferred revenue, net of current portion decreased by 12.6% to $1.03B in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Liabilities

CategoryGrowth

SignalHigher is better

VolatilityStable

First reportedQ2 2020

Last reportedQ1 2026

How to read this metric

An increase suggests strong long-term bookings and future revenue growth, while a decrease may indicate a slowdown in long-term contract renewals.

Detailed definition

This represents the portion of deferred revenue that is expected to be recognized as revenue beyond the next twelve mont...

Peer comparison

Common in SaaS and software companies; peers typically show growth in this metric as they scale enterprise subscriptions.

Metric ID: non_current_liabilities_contract_with_customer_liability_a5d23a

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$1.18B	$1.03B
QoQ Change	—	-12.6%

Range$1.03B – $1.18B

Deferred revenue, net of current portion at Other Companies

AmetekAME View metric

Frequently Asked Questions

What is Thermo Fisher Scientific's deferred revenue, net of current portion?: Thermo Fisher Scientific (TMO) reported deferred revenue, net of current portion of $1.03B in Q1 2026.
What does deferred revenue, net of current portion mean?: Revenue received in advance for services or products to be delivered more than one year in the future.